Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven for Prevention of Hypotension During Cesarean Section
NCT00694343Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Jun 2008
- Primary completion
- Dec 2009
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Volulyte in hypotension, sponsored by Fresenius Kabi. Started Jun 2008; status: completed.
02
Drugs
Volulyte
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT00694343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694343.